{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:37:35Z","timestamp":1790127455015,"version":"4.0.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T00:00:00Z","timestamp":1710028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T00:00:00Z","timestamp":1710028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-1-0382"],"award-info":[{"award-number":["W81XWH-18-1-0382"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CMMI-1751898"],"award-info":[{"award-number":["CMMI-1751898"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR052273"],"award-info":[{"award-number":["AR052273"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000138","name":"U.S. Department of Education","doi-asserted-by":"publisher","award":["Graduate Assistance in Areas of National Need Program Fellowship"],"award-info":[{"award-number":["Graduate Assistance in Areas of National Need Program Fellowship"]}],"id":[{"id":"10.13039\/100000138","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EB Research Partnership"},{"DOI":"10.13039\/100002077","name":"EB Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002077","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recessive dystrophic epidermolysis bullosa (RDEB) is a rare inherited skin disease characterized by defects in type VII collagen leading to a range of fibrotic pathologies resulting from skin fragility, aberrant wound healing, and altered dermal fibroblast physiology. Using a novel in vitro model of fibrosis based on endogenously produced extracellular matrix, we screened an FDA-approved compound library and identified antivirals as a class of drug not previously associated with anti-fibrotic action. Preclinical validation of our lead hit, daclatasvir, in a mouse model of RDEB demonstrated significant improvement in fibrosis as well as overall quality of life with increased survival, weight gain and activity, and a decrease in pruritus-induced hair loss. Immunohistochemical assessment of daclatasvir-treated RDEB mouse skin showed a reduction in fibrotic markers, which was supported by in vitro data demonstrating TGF\u03b2 pathway targeting and a reduction of total collagen retained in the extracellular matrix. Our data support the clinical development of antivirals for the treatment of patients with RDEB and potentially other fibrotic diseases.<\/jats:p>","DOI":"10.1038\/s44321-024-00048-8","type":"journal-article","created":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T07:01:47Z","timestamp":1710054107000},"page":"870-884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1403-7010","authenticated-orcid":false,"given":"Grace","family":"Tartaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8987-1317","authenticated-orcid":false,"given":"Ignacia","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Varughese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1552-0961","authenticated-orcid":false,"given":"Lauren E","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyung Hun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7196-4101","authenticated-orcid":false,"given":"Michael H","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Poojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6067-8209","authenticated-orcid":false,"given":"Qingqing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary M","family":"Padron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemima E","family":"Mellerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9196-841X","authenticated-orcid":false,"given":"Francis","family":"Palisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Salas-Alanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7650-0835","authenticated-orcid":false,"given":"Andrew P","family":"South","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,10]]},"reference":[{"key":"48_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jid.2020.10.024","volume":"141","author":"E Akasaka","year":"2021","unstructured":"Akasaka E, Kleiser S, Sengle G, Bruckner-Tuderman L, Nystr\u00f6m A (2021) Diversity of mechanisms underlying latent TGF-\u03b2 activation in recessive dystrophic epidermolysis bullosa. J Investig Dermatol 141:1450\u20131460","journal-title":"J Investig Dermatol"},{"key":"48_CR2","doi-asserted-by":"publisher","first-page":"7849","DOI":"10.3390\/ijms24097849","volume":"24","author":"F Amati","year":"2023","unstructured":"Amati F, Stainer A, Polelli V, Mantero M, Gramegna A, Blasi F, Aliberti S (2023) Efficacy of pirfenidone and nintedanib in interstitial lung diseases other than idiopathic pulmonary fibrosis: a systematic review. Int J Mol Sci 24:7849","journal-title":"Int J Mol Sci"},{"key":"48_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/srep04765","volume":"4","author":"DB Ascher","year":"2014","unstructured":"Ascher DB, Wielens J, Nero TL, Doughty L, Morton CJ, Parker MW (2014) Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA. Sci Rep 4:4765","journal-title":"Sci Rep"},{"key":"48_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1359-6101(99)00036-2","volume":"11","author":"GS Ashcroft","year":"2000","unstructured":"Ashcroft GS, Roberts AB (2000) Loss of Smad3 modulates wound healing. Cytokine Growth Factor Rev 11:125\u2013131","journal-title":"Cytokine Growth Factor Rev"},{"key":"48_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/12971","volume":"1","author":"GS Ashcroft","year":"1999","unstructured":"Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C et al (1999) Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1:260\u2013266","journal-title":"Nat Cell Biol"},{"key":"48_CR6","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jid.2019.01.011","volume":"139","author":"VS Atanasova","year":"2019","unstructured":"Atanasova VS, Russell RJ, Webster TG, Cao Q, Agarwal P, Lim YZ, Krishnan S, Fuentes I, Guttmann-Gruber C, McGrath JA et al (2019) Thrombospondin-1 is a major activator of TGF-\u03b2 signaling in recessive dystrophic epidermolysis bullosa fibroblasts. J Investig Dermatol 139:1497\u20131505.e1495","journal-title":"J Investig Dermatol"},{"key":"48_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2001-2-8-reviews3010","volume":"2","author":"L Attisano","year":"2001","unstructured":"Attisano L, Lee-Hoeflich ST (2001) The Smads. Genome Biol 2:Reviews3010","journal-title":"Genome Biol"},{"key":"48_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/08977194.2011.595714","volume":"29","author":"A Biernacka","year":"2011","unstructured":"Biernacka A, Dobaczewski M, Fau -, Frangogiannis NG, Frangogiannis NG (2011) TGF-\u03b2 signaling in fibrosis. Growth Factors 29:196\u2013202","journal-title":"Growth Factors"},{"key":"48_CR9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1053\/j.gastro.2016.11.047","volume":"152","author":"B Boson","year":"2017","unstructured":"Boson B, Denolly S, Turlure F, Chamot C, Dreux M, Cosset FL (2017) Daclatasvir prevents hepatitis C virus infectivity by blocking transfer of the viral genome to assembly sites. Gastroenterology 152:895\u2013907.e814","journal-title":"Gastroenterology"},{"key":"48_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1517\/17425255.2011.570333","volume":"7","author":"M Burnier","year":"2011","unstructured":"Burnier M, Wuerzner G (2011) Pharmacokinetic evaluation of losartan. Expert Opin Drug Metab Toxicol 7:643\u2013649","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"48_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72564-9","volume":"10","author":"A Cal\u00f2","year":"2020","unstructured":"Cal\u00f2 A, Romin Y, Srouji R, Zambirinis CP, Fan N, Santella A, Feng E, Fujisawa S, Turkekul M, Huang S et al (2020) Spatial mapping of the collagen distribution in human and mouse tissues by force volume atomic force microscopy. Sci Rep 10:15664","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"48_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/liv.12395","volume":"34","author":"V Calvaruso","year":"2014","unstructured":"Calvaruso V, Crax\u00ec A (2014) Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible? Liver Int 34(Suppl 1):85\u201390","journal-title":"Liver Int"},{"key":"48_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.matbio.2022.06.008","volume":"111","author":"Q Cao","year":"2022","unstructured":"Cao Q, Tartaglia G, Alexander M, Park PH, Poojan S, Farshchian M, Fuentes I, Chen M, McGrath JA, Palisson F et al (2022) Collagen VII maintains proteostasis in dermal fibroblasts by scaffolding TANGO1 cargo. Matrix Biol 111:226\u2013244","journal-title":"Matrix Biol"},{"key":"48_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.30802\/AALAS-CM-21-000063","volume":"72","author":"VM Chen","year":"2022","unstructured":"Chen VM, Southwell K, Huynh E, Gavett S, Richey L, Esmail M (2022) Corneal changes and strategies to improve survival of hypomorphic collagen VII-deficient mice for the study of ocular dystrophic epidermolysis bullosa. Comp Med 72:14\u201321","journal-title":"Comp Med"},{"key":"48_CR15","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.jfma.2020.11.018","volume":"120","author":"CH Cheng","year":"2021","unstructured":"Cheng CH, Chu CY, Chen HL, Lin IT, Wu CH, Lee YK, Hu PJ, Bair MJ (2021) Direct-acting antiviral therapy of chronic hepatitis C improves liver fibrosis, assessed by histological examination and laboratory markers. J Formos Med Assoc 120:1259\u20131268","journal-title":"J Formos Med Assoc"},{"key":"48_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.actbio.2020.05.005","volume":"111","author":"DR Chery","year":"2020","unstructured":"Chery DR, Han B, Li Q, Zhou Y, Heo SJ, Kwok B, Chandrasekaran P, Wang C, Qin L, Lu XL et al (2020) Early changes in cartilage pericellular matrix micromechanobiology portend the onset of post-traumatic osteoarthritis. Acta Biomater 111:267\u2013278","journal-title":"Acta Biomater"},{"key":"48_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.matbio.2018.12.001","volume":"81","author":"F Cianfarani","year":"2019","unstructured":"Cianfarani F, De Domenico E, Nystr\u00f6m A, Mastroeni S, Abeni D, Baldini E, Ulisse S, Uva P, Bruckner-Tuderman L, Zambruno G et al (2019) Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa. Matrix Biol 81:3\u201316","journal-title":"Matrix Biol"},{"key":"48_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78206-4","volume":"10","author":"SW Clayton","year":"2020","unstructured":"Clayton SW, Ban GI, Liu C, Serra R (2020) Canonical and noncanonical TGF-\u03b2 signaling regulate fibrous tissue differentiation in the axial skeleton. Sci Rep 10:21364","journal-title":"Sci Rep"},{"key":"48_CR19","doi-asserted-by":"crossref","unstructured":"Daclatasvir (2015) Daclatasvir. Aust Prescr 38: 217\u2013219","DOI":"10.18773\/austprescr.2015.077"},{"key":"48_CR20","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1016\/S0006-3495(02)75620-8","volume":"82","author":"EK Dimitriadis","year":"2002","unstructured":"Dimitriadis EK, Horkay F, Maresca J, Kachar B, Chadwick RS (2002) Determination of elastic moduli of thin layers of soft material using the atomic force microscope. Biophys J 82:2798\u20132810","journal-title":"Biophys J"},{"key":"48_CR21","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1172\/JCI34292","volume":"118","author":"A Fritsch","year":"2008","unstructured":"Fritsch A, Loeckermann S, Kern JS, Braun A, B\u00f6sl MR, Bley TA, Schumann H, von Elverfeldt D, Paul D, Erlacher M et al (2008) A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Investig 118:1669\u20131679","journal-title":"J Clin Investig"},{"key":"48_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s40262-017-0624-3","volume":"57","author":"Y Gandhi","year":"2018","unstructured":"Gandhi Y, Eley T, Fura A, Li W, Bertz RJ, Garimella T (2018) Daclatasvir: a review of preclinical and clinical pharmacokinetics. Clin Pharmacokinet 57:911\u2013928","journal-title":"Clin Pharmacokinet"},{"key":"48_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature08960","volume":"465","author":"M Gao","year":"2010","unstructured":"Gao M, Nettles RE, Belema M, Snyder LB, Nguyen VN, Fridell RA, Serrano-Wu MH, Langley DR, Sun JH, O\u2019Boyle 2nd DR et al (2010) Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465:96\u2013100","journal-title":"Nature"},{"key":"48_CR24","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s12325-016-0407-5","volume":"33","author":"T Garimella","year":"2016","unstructured":"Garimella T, You X, Wang R, Huang SP, Kandoussi H, Bifano M, Bertz R, Eley T (2016) A review of daclatasvir drug-drug interactions. Adv Ther 33:1867\u20131884","journal-title":"Adv Ther"},{"key":"48_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1083\/jcb.200606058","volume":"175","author":"G Ge","year":"2006","unstructured":"Ge G, Greenspan DS (2006) BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J Cell Biol 175:111\u2013120","journal-title":"J Cell Biol"},{"key":"48_CR26","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2174\/0929867321666131228222215","volume":"21","author":"I Gentile","year":"2014","unstructured":"Gentile I, Borgia F, Coppola N, Buonomo AR, Castaldo G, Borgia G (2014) Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5A. Curr Med Chem 21:1391\u20131404","journal-title":"Curr Med Chem"},{"key":"48_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1158\/1535-7163.MCT-10-0669","volume":"10","author":"C Gruber","year":"2011","unstructured":"Gruber C, Gratz IK, Murauer EM, Mayr E, Koller U, Bruckner-Tuderman L, Meneguzzi G, Hintner H, Bauer JW (2011) Spliceosome-mediated RNA trans-splicing facilitates targeted delivery of suicide genes to cancer cells. Mol Cancer Ther 10:233\u2013241","journal-title":"Mol Cancer Ther"},{"key":"48_CR28","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41591-022-01737-y","volume":"28","author":"I Gurevich","year":"2022","unstructured":"Gurevich I, Agarwal P, Zhang P, Dolorito JA, Oliver S, Liu H, Reitze N, Sarma N, Bagci IS, Sridhar K et al (2022) In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial. Nat Med 28:780\u2013788","journal-title":"Nat Med"},{"key":"48_CR29","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.bpj.2011.02.031","volume":"100","author":"L Han","year":"2011","unstructured":"Han L, Frank EH, Greene JJ, Lee HY, Hung HH, Grodzinsky AJ, Ortiz C (2011) Time-dependent nanomechanics of cartilage. Biophys J 100:1846\u20131854","journal-title":"Biophys J"},{"key":"48_CR30","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/bjd.13302","volume":"172","author":"H Hata","year":"2015","unstructured":"Hata H, Abe R, Suto A, Homma E, Fujita Y, Aoyagi S, Shimizu H (2015) MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa. Br J Dermatol 172:769\u2013773","journal-title":"Br J Dermatol"},{"key":"#cr-split#-48_CR31.1","unstructured":"He Y, Staschke KA, Tan SL (2006) HCV NS5A: a multifunctional regulator of cellular pathways and virus replication. In: Tan SL"},{"key":"#cr-split#-48_CR31.2","unstructured":"(ed) Hepatitis C viruses: genomes and molecular biology. Horizon Bioscience Copyright \u00a9 2006, Horizon Bioscience, Norfolk, UK, p 267-292"},{"key":"48_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S2055-6640(20)30691-9","volume":"2","author":"A Hill","year":"2016","unstructured":"Hill A, Simmons B, Gotham D, Fortunak J (2016) Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C. J Virus Erad 2:28\u201331","journal-title":"J Virus Erad"},{"key":"48_CR33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.matbio.2007.05.004","volume":"26","author":"DR Hopkins","year":"2007","unstructured":"Hopkins DR, Keles S, Greenspan DS (2007) The bone morphogenetic protein 1\/Tolloid-like metalloproteinases. Matrix Biol 26:508\u2013523","journal-title":"Matrix Biol"},{"key":"48_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1165\/rcmb.2003-0063OC","volume":"29","author":"B Hu","year":"2003","unstructured":"Hu B, Wu Z, Phan SH (2003) Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am J Respir Cell Mol Biol 29:397\u2013404","journal-title":"Am J Respir Cell Mol Biol"},{"key":"48_CR35","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1063\/1.1143970","volume":"64","author":"JL Hutter","year":"1993","unstructured":"Hutter JL (1993) Calibration of atomic\u2010force microscope tips. Rev Sci Instrum 64:1868\u20131873","journal-title":"Rev Sci Instrum"},{"key":"48_CR36","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1517\/14740338.2015.1100603","volume":"14","author":"SM Jafri","year":"2015","unstructured":"Jafri SM, Gordon SC (2015) The safety of daclatasvir for the treatment of hepatitis C. Expert Opin Drug Saf 14:1787\u20131797","journal-title":"Expert Opin Drug Saf"},{"key":"48_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/bjd\/ljac001","volume":"188","author":"JS Kern","year":"2023","unstructured":"Kern JS, Sprecher E, Fernandez MF, Schauer F, Bodemer C, Cunningham T, L\u00f6we S, Davis C, Sumeray M, Bruckner AL et al (2023) Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study. Br J Dermatol 188:12\u201321","journal-title":"Br J Dermatol"},{"key":"48_CR38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1365-2133.2008.08466.x","volume":"158","author":"AK Kivisaari","year":"2008","unstructured":"Kivisaari AK, Kallajoki M, Mirtti T, McGrath JA, Bauer JW, Weber F, K\u00f6nigov\u00e1 R, Sawamura D, Sato-Matsumura KC, Shimizu H et al (2008) Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas. Br J Dermatol 158:778\u2013785","journal-title":"Br J Dermatol"},{"key":"48_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/msb.2013.17","volume":"9","author":"V K\u00fcttner","year":"2013","unstructured":"K\u00fcttner V, Mack C, Rigbolt KT, Kern JS, Schilling O, Busch H, Bruckner-Tuderman L, Dengjel J (2013) Global remodelling of cellular microenvironment due to loss of collagen VII. Mol Syst Biol 9:657","journal-title":"Mol Syst Biol"},{"key":"48_CR40","unstructured":"LactMed (2006) Daclatasvir. In: Drugs and Lactation Database (LactMed\u00ae). National Institute of Child Health and Human Development, Bethesda, MD"},{"key":"48_CR41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.actbio.2017.02.043","volume":"54","author":"Q Li","year":"2017","unstructured":"Li Q, Qu F, Han B, Wang C, Li H, Mauck RL, Han L (2017) Micromechanical anisotropy and heterogeneity of the meniscus extracellular matrix. Acta Biomater 54:356\u2013366","journal-title":"Acta Biomater"},{"key":"48_CR42","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/rheumatology\/keab762","volume":"61","author":"FA Mendoza","year":"2022","unstructured":"Mendoza FA, Jimenez SA (2022) Serine\/threonine kinase inhibition as antifibrotic therapy: transforming growth factor-\u03b2 and Rho kinase inhibitors. Rheumatology 61:1354\u20131365","journal-title":"Rheumatology"},{"key":"48_CR43","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1158\/0008-5472.CAN-15-1348","volume":"76","author":"VR Mittapalli","year":"2016","unstructured":"Mittapalli VR, Madl J, L\u00f6ffek S, Kiritsi D, Kern JS, R\u00f6mer W, Nystr\u00f6m A, Bruckner-Tuderman L (2016) Injury-driven stiffening of the dermis expedites skin carcinoma progression. Cancer Res 76:940\u2013951","journal-title":"Cancer Res"},{"key":"48_CR44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.matbio.2016.06.004","volume":"56","author":"AM Muir","year":"2016","unstructured":"Muir AM, Massoudi D, Nguyen N, Keene DR, Lee SJ, Birk DE, Davidson JM, Marinkovich MP, Greenspan DS (2016) BMP1-like proteinases are essential to the structure and wound healing of skin. Matrix Biol 56:114\u2013131","journal-title":"Matrix Biol"},{"key":"48_CR45","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-11-2996","volume":"72","author":"YZ Ng","year":"2012","unstructured":"Ng YZ, Pourreyron C, Salas-Alanis JC, Dayal JH, Cepeda-Valdes R, Yan W, Wright S, Chen M, Fine JD, Hogg FJ et al (2012) Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Cancer Res 72:3522\u20133534","journal-title":"Cancer Res"},{"key":"48_CR46","doi-asserted-by":"crossref","unstructured":"Ng YZ, South AP (2014) Tissue engineering of tumor stromal microenvironment with application to cancer cell invasion. J Vis Exp 85:51321","DOI":"10.3791\/51321-v"},{"key":"48_CR47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00441-016-2457-z","volume":"365","author":"L Nissinen","year":"2016","unstructured":"Nissinen L, Farshchian M, Riihil\u00e4 P, K\u00e4h\u00e4ri VM (2016) New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma. Cell Tissue Res 365:691\u2013702","journal-title":"Cell Tissue Res"},{"key":"48_CR48","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.15252\/emmm.201505061","volume":"7","author":"A Nystr\u00f6m","year":"2015","unstructured":"Nystr\u00f6m A, Thriene K, Mittapalli V, Kern JS, Kiritsi D, Dengjel J, Bruckner-Tuderman L (2015) Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms. EMBO Mol Med 7:1211\u20131228","journal-title":"EMBO Mol Med"},{"key":"48_CR49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.virol.2013.06.032","volume":"444","author":"DR O\u2019Boyle Ii","year":"2013","unstructured":"O\u2019Boyle Ii DR, Sun J-H, Nower PT, Lemm JA, Fridell RA, Wang C, Romine JL, Belema M, Nguyen VN, Laurent DRS et al (2013) Characterizations of HCV NS5A replication complex inhibitors. Virology 444:343\u2013354","journal-title":"Virology"},{"key":"48_CR50","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejphar.2008.06.046","volume":"590","author":"H Oku","year":"2008","unstructured":"Oku H, Shimizu T, Kawabata T, Nagira M, Hikita I, Ueyama A, Matsushima S, Torii M, Arimura A (2008) Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol 590:400\u2013408","journal-title":"Eur J Pharmacol"},{"key":"48_CR51","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","volume":"24","author":"V Parvathaneni","year":"2019","unstructured":"Parvathaneni V, Kulkarni NS, Muth A, Gupta V (2019) Drug repurposing: a promising tool to accelerate the drug discovery process. Drug Discov Today 24:2076\u20132085","journal-title":"Drug Discov Today"},{"key":"48_CR52","unstructured":"Pfendner EG, Lucky AW (2018) Dystrophic Epidermolysis Bullosa. 2006 Aug 21 [Updated 2018 Sep 13]. In: Adam MP, Feldman J, Mirzaa GM, et al. (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle, Seattle (WA), 1993\u20132024"},{"key":"48_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15515","volume":"35","author":"MR Pourani","year":"2022","unstructured":"Pourani MR, Vahidnezhad H, Mansouri P, Youssefian L, Rakhshan A, Hajimoradi B, Abdollahimajd F, Uitto J (2022) Losartan treatment improves recessive dystrophic epidermolysis bullosa: a case series. Dermatol Ther 35:e15515","journal-title":"Dermatol Ther"},{"key":"48_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C et al (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41\u201358","journal-title":"Nat Rev Drug Discov"},{"key":"48_CR55","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5582\/irdr.2017.01005","volume":"6","author":"E Rashidghamat","year":"2017","unstructured":"Rashidghamat E, McGrath JA (2017) Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa. Intractable Rare Dis Res 6:6\u201320","journal-title":"Intractable Rare Dis Res"},{"key":"48_CR56","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/exd.14183","volume":"30","author":"P Riihil\u00e4","year":"2021","unstructured":"Riihil\u00e4 P, Nissinen L, K\u00e4h\u00e4ri VM (2021) Matrix metalloproteinases in keratinocyte carcinomas. Exp Dermatol 30:50\u201361","journal-title":"Exp Dermatol"},{"key":"48_CR57","doi-asserted-by":"publisher","first-page":"adv00523","DOI":"10.2340\/00015555-3875","volume":"101","author":"SJ Robertson","year":"2021","unstructured":"Robertson SJ, Orrin E, Lakhan MK, O\u2019Sullivan G, Felton J, Robson A, Greenblatt DT, Bernardis C, McGrath JA, Martinez AE, Mellerio JE et al (2021) Cutaneous squamous cell carcinoma in epidermolysis bullosa: a 28-year retrospective study. Acta Derm Venereol 101:adv00523","journal-title":"Acta Derm Venereol"},{"key":"48_CR58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tips.2021.01.003","volume":"42","author":"HI Roessler","year":"2021","unstructured":"Roessler HI, Knoers N, van Haelst MM, van Haaften G (2021) Drug repurposing for rare diseases. Trends Pharmacol Sci 42:255\u2013267","journal-title":"Trends Pharmacol Sci"},{"key":"48_CR59","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2165\/00003088-200544080-00003","volume":"44","author":"DA Sica","year":"2005","unstructured":"Sica DA, Gehr TW, Ghosh S (2005) Clinical pharmacokinetics of losartan. Clin Pharmacokinet 44:797\u2013814","journal-title":"Clin Pharmacokinet"},{"key":"48_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1060028015610342","volume":"50","author":"MA Smith","year":"2016","unstructured":"Smith MA, Regal RE, Mohammad RA (2016) Daclatasvir: a NS5A replication complex inhibitor for hepatitis C infection. Ann Pharmacother 50:39\u201346","journal-title":"Ann Pharmacother"},{"key":"48_CR61","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1172\/JCI110577","volume":"69","author":"GP Stricklin","year":"1982","unstructured":"Stricklin GP, Welgus HG, Bauer EA (1982) Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures. J Clin Investig 69:1373\u20131383","journal-title":"J Clin Investig"},{"key":"48_CR62","first-page":"36","volume":"10","author":"A Tabor","year":"2017","unstructured":"Tabor A, Pergolizzi Jr JV, Marti G, Harmon J, Cohen B, Lequang JA (2017) Raising awareness among healthcare providers about epidermolysis bullosa and advancing toward a cure. J Clin Aesthet Dermatol 10:36\u201348","journal-title":"J Clin Aesthet Dermatol"},{"key":"48_CR63","doi-asserted-by":"publisher","first-page":"e1000032","DOI":"10.1371\/journal.ppat.1000032","volume":"4","author":"TL Tellinghuisen","year":"2008","unstructured":"Tellinghuisen TL, Foss KL, Treadaway J (2008) Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog 4:e1000032","journal-title":"PLoS Pathog"},{"key":"48_CR64","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/humu.20647","volume":"29","author":"M Titeux","year":"2008","unstructured":"Titeux M, Pendaries V, Tonasso L, D\u00e9cha A, Bodemer C, Hovnanian A (2008) A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa. Hum Mutat 29:267\u2013276","journal-title":"Hum Mutat"},{"key":"48_CR65","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/BOR.0b013e32833038ce","volume":"21","author":"M Trojanowska","year":"2009","unstructured":"Trojanowska M (2009) Noncanonical transforming growth factor beta signaling in scleroderma fibrosis. Curr Opin Rheumatol 21:623\u2013629","journal-title":"Curr Opin Rheumatol"},{"key":"48_CR66","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0167-5699(97)01126-2","volume":"18","author":"E Wakeland","year":"1997","unstructured":"Wakeland E, Morel L, Achey K, Yui M, Longmate J (1997) Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today 18:472\u2013477","journal-title":"Immunol Today"},{"key":"48_CR67","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fphar.2017.00461","volume":"8","author":"KL Walton","year":"2017","unstructured":"Walton KL, Johnson KE, Harrison CA (2017) Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis. Front Pharmacol 8:461","journal-title":"Front Pharmacol"},{"key":"48_CR68","doi-asserted-by":"publisher","first-page":"pe13","DOI":"10.1126\/stke.110pe13","volume":"1","author":"RG Wells","year":"2008","unstructured":"Wells RG, Discher DE (2008) Matrix elasticity, cytoskeletal tension, and TGF-beta: the insoluble and soluble meet. Sci Signal 1:pe13","journal-title":"Sci Signal"},{"key":"48_CR69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1124\/jpet.113.208223","volume":"349","author":"L Wollin","year":"2014","unstructured":"Wollin L, Maillet I, Quesniaux V, Holweg A, Ryffel B (2014) Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. J Pharmacol Exp Ther 349:209\u2013220","journal-title":"J Pharmacol Exp Ther"},{"key":"48_CR70","first-page":"1194","volume":"57","author":"K Yoshinaga","year":"1999","unstructured":"Yoshinaga K (1999) [Drug-interactions and adverse effects of losartan potassium, an angiotensin II receptor antagonist]. Nihon Rinsho 57:1194\u20131197","journal-title":"Nihon Rinsho"},{"issue":"4","key":"48_CR71","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2174\/1874467213666200116114919","volume":"13","author":"S Zakaria","year":"2020","unstructured":"Zakaria S, El-Sisi AE (2020) Daclatasvir and sofosbuvir mitigate hepatic fibrosis through downregulation of TNF-\u03b1\/NF-\u03baB signaling pathway. Curr Mol Pharmacol 13(4):318\u2013327","journal-title":"Curr Mol Pharmacol"},{"key":"48_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-020-4916-6","volume":"13","author":"C Zhang","year":"2020","unstructured":"Zhang C, Li H, Han R (2020) An open-source video tracking system for mouse locomotor activity analysis. BMC Res Notes 13:48","journal-title":"BMC Res Notes"},{"key":"48_CR73","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE (2009) Non-Smad pathways in TGF-beta signaling. Cell Res 19:128\u2013139","journal-title":"Cell Res"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00048-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-024-00048-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00048-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:47:42Z","timestamp":1779065262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-024-00048-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,10]]},"references-count":74,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,15]]}},"alternative-id":["48"],"URL":"https:\/\/doi.org\/10.1038\/s44321-024-00048-8","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,10]]},"assertion":[{"value":"30 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}